Literature DB >> 15340543

[Comparison of hepatitis B virus serotype and genotype among HBsAg positive hepatitis B patients in a northern and a southern city of China].

Jun Xu1, Qi-xin Wang, Chun-lei Fan, Dong Jiang, Ruo-bing Li, Xu Cong, Ran Fei, Hong-song Chen, Lai Wei, Yu Wang.   

Abstract

OBJECTIVE: To understand HBV serotypes and genotypes epidemiology in a northern city and a southern city in China.
METHODS: Using polymerase chain reaction (PCR) and direct sequencing of HBV DNA PCR products, the serotypes and genotypes of HBV in 530 from HBsAg positive samples. The enrolled patients were from Harbin, a northern city and Lianjiang, a southern city in China.
RESULTS: Comparison of the serotypes and genotypes of HBV between Harbin and Lianjiang showed that adrq+ was the most predominant hepatitis B virus serotype in both Harbin and Lianjiang (87.2% and 73.5%,respectively), adw2 was the next (12.0% and 25.7%, respectively); genotype C was the most frequent in Harbin and Lianjiang (87.8% and 73.2%, respectively), and genotype B was the next (12.2% and 26.1%, respectively) only 1 patient was infected by genotype D, and 1 patient was found to be co-infected by genotype B and C in Lianjiang.
CONCLUSION: The results suggest that the percentage of HBV serotypes and genotypes between Harbin and Lianjiang was significantly different (P less than 0.001), but the main HBV serotype and genotype of the two cities were similar.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15340543

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  2 in total

1.  Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.

Authors:  Hong-Quan Li; Zhuo Li; Ying Liu; Jun-Hong Li; Jian-Qun Dong; Ji-Rong Gao; Chun-Yan Gou; Hui Li
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

2.  S gene mutations of HBV in children with HBV-associated glomerulonephritis.

Authors:  Hongzhu Lu; Hui Zhu; Jianhua Zhou
Journal:  Virol J       Date:  2012-03-05       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.